2003～2007年科学引文索引扩展版药理学和药剂学领域高影响因子期刊论文分析  

Analysis of SCIE Journal Articles with High Impact Factor on Pharmaceutics and Pharmacology from 2003 to 2007

作　　者：阿丽塔[1] 许培扬[1] 王敏[1] 张玢[1] 张燕舞[1] 

机构地区：[1]中国医学科学院医学信息研究所/图书馆,北京市100005

出　　处：《中国药房》2010年第5期462-465,共4页China Pharmacy

基　　金：中央级公益性科研院所基本科研业务费(09R0112)

摘　　要：目的:为药学科研工作者提供科学引文索引扩展版药理学和药剂学领域高影响因子期刊论文的相关信息。方法:根据美国科学信息研究所发布的2007期刊引证报告网络版筛选出药理学和药剂学领域影响因子排名前10位的期刊,在科学引文索引扩展版中套录2003～2007年10种期刊发表的全部论文,利用论文分析软件Thomson Data Analyzer对套录的论文从多角度进行分析。结果与结论:10种期刊在2003～2007年发文量稳定;论文类型以Review和Meeting Abstract为主;发文量排名前10的国家和机构集中在欧美发达国家;研究热点集中在癌症、心血管疾病、白血病、艾滋病等领域,研究已深入到分子生物学水平。鉴于此,我国药学科研工作者在发表专业文章时可选择高影响力期刊,提高论文影响力。OBJECTIVE： To provide related information about SCIE journal articles with high impact factor on pharmaceutics and pharmacology for pharmaceutics researchers. METHODS： Top 10 journals in list of impact factor in the field of pharmaceutics and pharmacology were collected from 2007 JCR （network edition） issued by Institute of Scientific Information. Thomson Data Analyzer software was used to analyze journal articles involved in JCR comprehensively. RESULTS ＆ CONCLUSIONS： From 2003 to 2007, the amount of published papers kept steady in the 10 kinds of journals; Review and Meeting Abstract were the main types of papers. Developed countries and their institutes dominated the top 10 places including Europe and American in the list of amount of published papers. The literatures mainly focused on cancer, angiocardiopathy, leukemia, AIDS and so on, which touched upon molecular biology. Pharmacy researchers should choose the journal with high impact factor when they prepare to publish their papers in order to improve the influence of papers.

关 键 词：药理学 药剂学 期刊 影响因子 论文 分析 

分 类 号：R94[医药卫生—药剂学] R95[医药卫生—药学]